7.5.65: VMA 3-4 pg/mg creatinine. 28.3.66: Liver function tests normal.
Progress: The patient has remained well; his liver has shrunk in size and is now barely palpable. He has continued on cyclophosphamide 25 mg b.d. for three and a half years without any side-effects. Family history: Fatherpolycystic kidneys diagnosed aged 2 years; convulsions as a teenager; aged 25, renal failure for five weeks before death, post-mortem showed polycystic kidneys which included an adenoma, adenoma sebaceum on nose and chin, tuberous sclerosis of brain. Mother and two siblings well. No positive history in father's family.
Investigations: Blood urea 28 mg/100 ml. Creatinine clearance 19 (normal 37) ml/min. VMA: Gitlow's ratio 1-3:1 (below normal). 17-ketosteroids 0-87 mg/day. 17-ketogenic steroids 3 05 mg/day. IVP suggested polycystic disease. EEG showedan area of abnormal activity in right temporal region.
Treatment with phenobarbitone and bethanidine was begun.
Progress: Blood pressure rose to 210/160, and fell to 140/90 with treatment. ECG showed left ventricular preponderance. Developmentally retarded. Histology: Initially considered to be a fibros'arcoma (Fig 1) . However, Dr H A Sissons reported: 'This is an example of a juvenile aponeurotic fibroma. These lesions have a tendency to recur after local removal, but ultimately become quiescent and are entirely nonmalignant'.
